在合式对接中产生了小分子负调节器,其目标是Frizzled 7的核心
Magdalena M Scharf1, Julia Kinsolving1, Lukas Grätz1,2
1Department of Physiology & Pharmacology, Sec Receptor Biology & Signaling, Biomedicum, Karolinska Institute, Stockholm, Sweden.
研究人员确定了一种小分子C407,它有效地准Frizzled 7 (FZD7) 受体. 这一突破表明了开发小分子药物的潜力,以调节WNT信号通路,用于治疗应用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- 针对Frizzled (FZD) 受体,对于WNT信号发送至关重要,在治疗上是有前途的,但由于缺乏有效的小分子,具有挑战性.
- 对于FZD受体,尚未确定任何经过验证的连接体结合部位,这阻碍了药物开发.
研究的目的:
- 确定和验证Frizzled 7 (FZD7) 的小分子抑制剂,这是肠道瘤的潜在目标.
- 为了证明用小分子准FZD受体的可行性.
主要方法:
- 利用适应的对接设置和大型分子库对接屏幕来识别潜在的化合物.
- 用药理学测试,生物传感器,突变发生,冷电子显微镜和分子动力学模拟进行验证.
- 验证了FZD7.7的跨膜束内的化合物结合部位.
主要成果:
- 已确定化合物C407作为FZD7.7的调节器.
- 证实C407作为WNT/β-catenin信号传输的负调节器.
- 验证了FZD7跨膜捆的核心中C407的结合部位.
结论:
- 提供了用小分子化合物准Frizzled受体的原理证明.
- C407代表了开发针对FZD介导信号的治疗方法的潜在起点.
- 临床探索需要进一步优化和验证.
更多相关视频
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Ligand Binding and Linkage
Protein-protein Interfaces
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
